252 related articles for article (PubMed ID: 27736287)
1. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
Nakase K; Kita K; Kyo T; Katayama N
Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
[No Abstract] [Full Text] [Related]
2. G-CSF for chromosome analysis of myeloid leukemias and MDS.
Tsuchiya H; Higuchi S; Asou N; Yamaguchi K; Matsuda I; Yokoyama Y; Murakami T; Kaneko Y
Cancer Genet Cytogenet; 1990 Jul; 47(2):277-9. PubMed ID: 1694102
[No Abstract] [Full Text] [Related]
3. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
4. Chromosome abnormalities in hematopoietic malignancies.
Kamada N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1332-8. PubMed ID: 3073610
[No Abstract] [Full Text] [Related]
5. [Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML)].
Kitamura T; Watanabe-Okochi N; Inoue D; Togami K; Uchida T; Kagiyama Y; Kawabata K; Chiba S; Harada Y; Harada H; Kitaura J; Nakahara F
Rinsho Ketsueki; 2012 Aug; 53(8):734-9. PubMed ID: 22975812
[No Abstract] [Full Text] [Related]
6. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
[TBL] [Abstract][Full Text] [Related]
7. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
8. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis.
Kaneko Y; Maseki N; Sakurai M; Shibuya A; Shinohara T; Fujimoto T; Kanno H; Nishikawa A
Leukemia; 1989 Jan; 3(1):36-41. PubMed ID: 2491896
[TBL] [Abstract][Full Text] [Related]
9. [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia].
Gritsaev SV; Kostroma II; Zapreev IM; Shmidt AV; Tiranova SA; Balashova VA; Martynkevich IS; Chubukina ZV; Semenova NY; Chechetkin AV
Ter Arkh; 2016; 88(7):104-108. PubMed ID: 27459623
[TBL] [Abstract][Full Text] [Related]
10. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
Onozawa M; Fukuhara T; Takahata M; Yamamoto Y; Miyake T; Maekawa I
Ann Hematol; 2003 Sep; 82(9):593-5. PubMed ID: 12898186
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelogenous leukemia as a model of cancer development.
Butturini A; Gale RP
Semin Oncol; 1995 Aug; 22(4):374-9. PubMed ID: 7638634
[No Abstract] [Full Text] [Related]
12. Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia.
Gong Z; Xu ML; Chen M; Cui W; Kantarjian HM; Cortes JE; Zhou T; Tang G; Wang W; Medeiros LJ; Hu S
Am J Hematol; 2019 Oct; 94(10):E256-E259. PubMed ID: 31273842
[No Abstract] [Full Text] [Related]
13. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
Advani AS
Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
[No Abstract] [Full Text] [Related]
14. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias.
Liang R; Chan VV; Chan TK; Chiu E; Todd D
Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide.
Oka S; Ono K; Nohgawa M
Leuk Lymphoma; 2017 Oct; 58(10):2511-2513. PubMed ID: 28278708
[No Abstract] [Full Text] [Related]
17. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
18. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
[TBL] [Abstract][Full Text] [Related]
19. GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.
Qian Z; Qian J; Lin J; Yao DM; Chen Q; Ji RB; Li Y; Xiao GF; Li JY
J Exp Clin Cancer Res; 2010 Aug; 29(1):111. PubMed ID: 20704716
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
